COVID-19 PCR Test Kit
Rapid and clinically-relevant results for your patients and community. CE-IVD* approved for point-of-care (POC) PCR.
- Detect Omicron and Delta Variants with bioinformatic analysis and 99.64% of all known variants.
- Sensitive Real-Time-PCR testing within 65 minutes.
- RNA extraction is not required.
- Minimal hands-on time per sample.
- Pool up to 10 samples for screening.
CE-IVD products are available for any markets that accept CE marking as the valid regulatory approval. RUO products are for Research Use Only and are not for use in diagnostic procedures.
Validated through clinical trials
100 % Sensitivity
Every positive test sample was correctly identified in clinical studies.
100 % Specificity
Every negative test sample was correctly identified in clinical studies.
99.64% Inclusivity
Our analyzer detects 99.64% of all known COVID-19 variants.
~3 min. from reagant thaw, No extraction required.
Orf1ab polyprotein and N gene; Detects B.1.351 and B.1.1.7. variants (does not differentiate)
(10.31 inches x 5.16 inches x 10.16 inches)
Ideal for clinical and community-level testing
On-site care creates a high quality, case-by-case testing solution for:
- Emergency Departments
- Delivery Wards
- Outpatient Procedures
- Surgical Procedures
Setting up multiple Fluxergy analyzers allows for community-level testing in settings such as:
- Testing Centers
- Airports
- Workplace
- Screening
- Travel Certifications
- In-Person School Testing
FAQs
The Fluxergy Test Kit utilizes state-of-the-art Sample-to-Answer-RT-PCR and microfluidics technology and can identify the SARS-CoV-2 virus in 1 hour.
Fluxergy’s simple workflow and compact analyzer is deal for use in clinics and laboratories. Enable access to point-of-care testing in physician’s offices, hospitals, and community clinics. Fluxergy’s rapid testing can compliment a laboratory’s throughput workflow. 1 hour PCR testing as a service provides valuable time in clinical and retail settings.
Still have questions?
Articles & resources
See related resources, articles, news, and insights
_IMG.png)
HVRe Influenza / RSV / SARS-CoV-2 Respiratory Panel
.svg)
.svg)
Testimonials
“I learned of Fluxergy’s technology when I was at Boehringer Ingelheim, and I was impressed about the opportunity for this point-of-care testing platform. I am happy to be involved on Fluxergy’s advisory board where I can bring my 20+ years of animal health and R&D experience. One of the big advantages of Fluxergy’s technology is that it is very easy to use. When veterinarians see horses with high fevers, its important that they can understand quickly what is going on.”
Dr. Randolph Seidler, VMD, MBA
Boehringer Ingelheim
“Two things about the Fluxergy system stand out, especially in the case of a viral pandemic: its accuracy using RT-PCR technology and its ability to deliver results in 1 hour at the point-of-care.”
Dr. David Smith, MD, MAS, FACP, FIDSA
UCSD
